UNITED THERAPEUTICS CORPORATION v. ACTAVIS LABORATORIES FL, INC.
3:16-cv-01816
Overview
Parties
Defendant
ACTAVIS LABORATORIES FL, INC. Operating Company
Represented By
3 Attorneys ListedWALSH PIZZI O'REILLY FALANGA LLP
THREE GATEWAY CENTER, 100 MULBERRY STREET
WALSH PIZZI O'REILLY FALANGA LLP
THREE GATEWAY CENTER, 100 MULBERRY STREET
Plaintiff
SUPERNUS PHARMACEUTICALS, INC. Operating Company
Represented By
3 Attorneys ListedSAUL EWING ARNSTEIN & LEHR LLP
ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.
SAUL EWING ARNSTEIN & LEHR LLP
1037 RAYMOND BOULEVARD, SUITE 1520
SAUL EWING ARNSTEIN & LEHR LLP
ONE RIVERFRONT PLAZA, NEWARK, NJ 07102-5490
UNITED THERAPEUTICS CORPORATION NPE (Individual / Inventor)
Represented By
3 Attorneys ListedSAUL EWING ARNSTEIN & LEHR LLP
ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.
SAUL EWING ARNSTEIN & LEHR LLP
1037 RAYMOND BOULEVARD, SUITE 1520
SAUL EWING ARNSTEIN & LEHR LLP
ONE RIVERFRONT PLAZA, NEWARK, NJ 07102-5490
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8349892
Solid formulations of prostacyclin analogs
|
Filed: 2010-05-06
Issued: 2013-01-08
|
Active (4.2 yrs remaining)
+261d PTA
Expires: 2031-01-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+261 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
17
Dispositive
4
Granted
5
Denied
0
Pending / Review
8
Motions by Category
Key Dispositive Motions & Rulings